Noninvasive techniques exist to support the asthmatic patient who has not made a full recovery. NIPPV is valuable in supporting patients with significant respiratory distress and may either delay or resolve the requirement for intubation. The patient must be alert with spontaneous breaths to receive non-invasive therapies.
NIPPV provides positive pressure ventilation via a mask adequately sealed to the face to support the spontaneously breathing individual. Devices cover the nose, the nose with the mouth, or the entire face. With bilevel settings, providers can control pressure received at both inspiration and expiration.
The significant benefit of NIPPV is that patients may not require intubation, which has significant adverse effects. There is an associated reduction in morbidity, as well as mortality and difficulty in care and costs, are reduced.
The steps of administering NIPPV are:
Patients must meet certain requirements to receive NIPPV:
On the other hand, certain findings make patients ineligible for NIPPV:
The bi-level setting is more effective during an acute asthmatic episode. Its benefit is that it opposes the development of auto-PEEP and decreases breathing work more than other non-invasive techniques. It assists inspiratory effort while also decreasing the force needed in exhalation. The typical settings are inspiratory pressure between 8-10 cm H20 and expiratory pressure between 3-5 cm H20.
The decision to proceed to advanced airway management is not to be taken lightly. This treatment does not manage the bronchoconstriction of small airways. It can actually worsen bronchoconstriction via complications of auto-PEEP as well as barotrauma. It is necessary, however, if the patient is clinically deteriorating despite maximal therapy.
A patient connected to a mechanical ventilator.
The patients who are candidates for advanced airway management include those:
Asthmatic patients requiring intubation are at high risk for rapid desaturation even with adequate preoxygenation. Typically, these patients will need bac mask ventilation before and between intubation attempts. Be aware that patients may develop hypotension or cardiac arrest due to associated volume loss, sedative use, and trapped air.
Premedications for intubation include LOAD (lidocaine, opiates, atropine, and defasciculating agents)
Lidocaine Injection Preparation
Anesthetics are helpful as they often produce bronchodilation. Ketamine and propofol have increased efficacy in this regard.
It is a systemic anesthetic with dissociative properties that causes both dilation of the bronchial tree and increased bronchial secretions. Additionally, there is no associated vasodilation, hypotension, or cardiac depression. The dosage is 1-2 mg/kg. The effect is within 30-60 seconds and is ongoing for 10-20 minutes. It is often considered the preferred anesthetic for asthma patients requiring intubation. Atropine or glycopyrrolate can be given to minimize secretions.
This sedative also provides bronchodilation and can be used for intubation as well as during treatment with mechanical ventilation. The dosage is 1-2 mg/kg. The effect is under 1 minute and is ongoing for 5-10 minutes. Note that there can be associated hypotension, especially in those who have had prolonged exacerbation and are volume depleted.
This hypnotic can be used, but there is no associated bronchodilation or analgesic. It does cause less hemodynamic changes than propofol. The dosage is 0.2-0.4 mg/kg. The effect is under 1 minute and is ongoing for 5-10 minutes.
While intubation supports inadequate ventilation, it does not address the airway obstruction. The patient may have associated respiratory acidosis that persists even following intubation. The patient will need ongoing management of the obstructed airway.
Inhaled beta 2 agonists: these are continued, and an additional dose of 2.5-5 mg albuterol is given via the ETT as this may improve the delivery of the medication.
Slowly ventilate using 100% oxygen: note that there can still be obstructed airflow with the ETT in place.
The rate of ventilation should be between 6-10 breaths each minute with a tidal volume setting between 6-8 mL/kg. Additionally, short inspiratory time (rate of flow 80-100 L/min) with long expiratory time is recommended to achieve an inspiratory-respiratory ratio of 1:4 or 1:5. The combination of slowed rate and prolonged exhalation can help diminish auto PEPE and minimize the complications of pneumothorax or hypotension.
An acceptable strategy for intubation is as follows:
Even following intubation, severe asthma requires close monitoring and management.
Asthmatics have obstruction of the airflow throughout the respiratory cycle, but the obstruction is at its greatest during expiration. As obstruction progresses, the air becomes trapped, leading to stacked breaths in which the inhaled air cannot be exhaled.
Patients with severe asthma will have a longer expiration to attempt to exhale more air. If during mechanical ventilation, the exhaled time is too short, then auto-PEEP can result. The pressures at the end of exhalation become greater than mechanical PEEP settings, and the resulting increase in thoracic pressure occurs. The consequences are grave, with poor cardiac output, hemodynamic instability, and hypotension resulting. Patients may also suffer from barotrauma, including tension pneumothorax.
To manage these complications, a slowed breath rate (between 6-10 breaths each minute), a small tidal volume (between 6-8 mL/kg), shorter inspiration time (rate of flow 80-100 L/min) with long expiratory time is recommended to achieve an inspiratory-respiratory ratio of 1:4 or 1:5. Start positive inspiratory pressure at 10 cm H20 and keep below 25 cm H20. Additionally, keep peak inspiration pressure below 40 cm H20 to limit barotrauma.
Auto-PEEP
While oxygenation can adequately be increased once mechanical ventilation is started, it may still be difficult to release carbon dioxide. Hypoventilation is actually encouraged as this minimizes auto-PEEP and complications of barotrauma. These patients should have mechanical settings that allow a mildly increased PaCO2 to diminish adverse effects.
In this case, ventilatory settings should minimize auto-PEEP, and this will cause a slow rise in PaCO2 that can be as high as 70-90 mm Hg at 3-4 hours. Associated respiratory acidosis will occur with a pH that may go as low as 7.2-7.3; however, PaCO2 can be managed to limit this. Note that in the next 24-48 hours, compensatory metabolic alkalosis will occur as the kidneys reabsorb bicarbonate, and the pH will return towards normal.
Monitor patient response to acidosis before metabolic correction. Some patients may develop acidosis associated arrhythmia and will require a reduction in acidosis or slower elevation of hypercapnia. Note also that patients will need significant sedation with settings that limit auto-PEEP and lead to hypercapnia.
In the patient who deteriorates following intubation:
Adequately assess the patient that is difficult to ventilate. While difficult to assess, there are four common causes of this situation, known as DOPE:
Intubation Procedure
The sequence of steps to manage the hard to ventilate include:
Following intubation, four reasons are commonly the cause of persisting hypotension or hypoxia.
Always reconfirm ETT placement if there is a change in exhaled CO2 or O2 saturation. Use clinical parameters to determine placement, rather than a chest x-ray, as that is too time-consuming. Waveform capnography is most reliable for determining displacement and can be used quickly to guide treatment.
Evaluate for ETT patency if the patient is difficult to ventilate. Suction as needed to clear obstructions and rule out mucus plugs, biting, and kinking of the ETT.
Significant hypotension following intubation is most commonly secondary to profound auto-PEEP. Manage by briefly stopping ventilation. This will help release auto-PEEP. Closely monitor oxygenation ad restart the ventilation once auto-PEEP is released or if the patient becomes hypoxemic
A tension pneumothorax is an emergency. Patients may have a poor expansion of the chest, reduced breath sounds, a tracheal shift away from the pneumothorax and subcutaneous emphysema. Management is with immediate needle thoracostomy. Use a 16 gauge needle with a cannula to pierce at the level of the 2nd intercostal space on the midclavicular line. The patient may require chest tube placement or other measures following the initial release.
Key Takeaway
Needle thoracostomy should only be done in patients with high clinical suspicion or confirmed pneumothorax.